First splicing variant in HECW2 with an autosomal recessive pattern of inheritance and associated with NDHSAL.
María Elena Rodríguez-GarcíaFrancisco Javier Cotrina-VinagreMarcello BellusciLaura Hernández-SánchezAna Martínez de AragónEduardo López-LasoElena Martín-HernándezFrancisco Martínez-AzorínPublished in: Human mutation (2022)
We report the clinical and genetic features of a Caucasian girl who presented a severe neurodevelopmental disorder with drug-resistant epilepsy, hypotonia, severe gastro-esophageal reflux and brain magnetic resonance imaging anomalies. WES uncovered a novel variant in homozygosis (g.197092814_197092824delinsC) in HECW2 gene that encodes the E3 ubiquitin-protein ligase HECW2. This protein induces ubiquitination and is implicated in the regulation of several important pathways involved in neurodevelopment and neurogenesis. Furthermore, de novo heterozygous missense variants in this gene have been associated with neurodevelopmental disorder with hypotonia, seizures, and absent language (NDHSAL). The homozygous variant of our patient disrupts the splice donor site of intron 22 and causes the elimination of exon 22 (r.3766_3917+1del) leading to an in-frame deletion of the protein (p.Leu1256_Trp1306del). Functional studies showed a twofold increase of its RNA expression, while the protein expression level was reduced by 60%, suggesting a partial loss-of-function mechanism of pathogenesis. Thus, this is the first patient with NDHSAL caused by an autosomal recessive splicing variant in HECW2.
Keyphrases
- drug resistant
- copy number
- magnetic resonance imaging
- genome wide
- intellectual disability
- early onset
- multidrug resistant
- mitochondrial dna
- protein protein
- binding protein
- case report
- amino acid
- poor prognosis
- autism spectrum disorder
- computed tomography
- gene expression
- cerebral ischemia
- resting state
- duchenne muscular dystrophy
- functional connectivity